About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 53 record(s)
Req # A-2021-10666
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Sanofi Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
February 2022
Req # A-2020-31
Seeking any briefing notes, memos, or related documents held by FedDev Ontario regarding L3 Harris Technologies Canada and related entities such as L3Harris Wescam (also referred to as L3 Wescam or WESCAM). This includes any FedDev emails or meeting notes pertaining to communications with their representatives, or with either the Canadian Commercial Corporation or Innovation, Science and Economic Development Canada regarding this firm. Only requesting materials limited to the time period of October 2019 to October 2020, inclusive. No material related to cabinet confidence or proprietary financial information is being requested. Only include emails that are from the Director level or higher – all others can be excluded. Exclude in its entirety the provision of contact information for L3 representatives to clients. Draft versions of documents/records can be excluded for cases where final versions existOrganization: Federal Economic Development Agency for Southern Ontario
February 2021
Req # A-2020-41
Please provide all ProServices contracts issued in the National Capital Region for the months of October 2020, November 2020, & December 2020. Please provide copies of contracts and callups.Organization: Federal Economic Development Agency for Southern Ontario
February 2021
Req # A-2020-42
Please provide all Task & Solutions Professional Services (TSPS) and Task Based Informatics Professional Services (TBIPS) Supply Arrangement (SA) contracts and Standing Offer (SO) callups issued in the National Capital Region for the months of October 2020, November 2020, & December 2020. Please provide copies of contracts and callups.Organization: Federal Economic Development Agency for Southern Ontario
February 2021
Req # A-2020-43
Please provide all Temporary Help Services (THS) Supply Arrangement (SA) and Standing Offer (SO) callups issued in the National Capital Region for the months October 2020, November 2020, & December 2020. Please provide copies of contracts and callups.Organization: Federal Economic Development Agency for Southern Ontario
February 2021
Req # A-2020-00811
Provide the specific dollar penalties and total claimed by the PMPRB from the use of excessive prices penalty since 2005 and documentation showing what the money was used for.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-00813
Copies of documents related to the use of the excessive price penalty against Alexion Pharmaceuticals.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-14747
Copies of meeting minutes, presentations and speaking notes associated with rare disease drugs from May 1, 2020 to July 31, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-18436
Provide a detailed disclosure of all third parties consultations over regulation and pricing of new drugs from June 1, 2019 to November 19, 2020, broken down by date, meeting minutes, and summary of meetings.Organization: Patented Medicine Prices Review Board Canada
February 2021
Req # A-2020-18440
Copies of all reports, email exchanges, memos, briefing notes, PowerPoints and other similar documents regarding the regulatory process of the United States Food and Drug Administration and the European Union's Medicines Agency compared to the PMPRB guidelines from June 1, 2019 to November 19, 2020.Organization: Patented Medicine Prices Review Board Canada
February 2021